WEBULL
WebtradeDownload

Reinsurance Group of America (RGA) Nears Argus Target As Its Undervalued Narrative Holds

Simply Wall St · 2d ago

Argus recently lifted its price objective for Reinsurance Group of America (RGA) to US$284, a move that sharpened investor attention on the reinsurer’s global footprint and current share valuation.

Recent trading has leaned in Reinsurance Group of America’s favor, with the share price at US$266.75 after a 1-day share price return of 1.03%, a 30-day share price return of 8.58%, and a 1-year total shareholder return of 44.05%. This points to firm positive momentum that investors are now weighing against the reinsurer’s broader valuation and risk profile.

Scan beyond Reinsurance Group of America’s latest price target move and compare it with a curated set of insurers and financially strong businesses using our list of solid balance sheet and fundamentals (25 results)

Reinsurance Group of America now trades close to Argus’s new target, yet carries a wide implied discount to estimated fair value. Is that a mispricing, or a sensible cushion for the risks in a global reinsurer?

Most Popular Narrative: 4% Undervalued

Reinsurance Group of America closed at $266.75, while the most followed narrative pegs fair value at about $277.33 using a 7.24% discount rate. That gap puts the focus on how capital strength, biometric earnings and Asia Pacific growth are feeding into long term return potential.

Recent material improvements in deployable and excess capital, including about US$2.2b of excess capital, nearly US$500 million deployed into in-force transactions year to date, a 20% to 30% payout ratio and plans to pay down US$400 million of debt in September 2026, provide flexibility to fund new business and shareholder returns that can support earnings and book value growth.

See why 24 investors see Reinsurance Group of America as 4% undervalued.

Result: Fair Value of $277.33 (UNDERVALUED)

Still, the story can change fast if pension risk transfer volumes stay weak and those 6% revenue and margin assumptions for Reinsurance Group of America prove too optimistic.

Find out about the key risks to this Reinsurance Group of America narrative.

Another View: What P/E Says About Reinsurance Group of America

The SWS fair value work paints Reinsurance Group of America as undervalued, yet the P/E picture is more cautious. RGA trades on 11.6x earnings versus a US insurance average of 11x and a peer group closer to 7.2x, while the fair ratio sits at 11.7x.

That mix points to a stock priced roughly in line with its own fair ratio, but carrying a clear premium to peers. For you, the question is whether RGA’s track record, capital position and earnings profile justify paying more than the sector now, or if the gap simply adds valuation risk.

See what the numbers say about this price — find out in our valuation breakdown.

NYSE:RGA P/E Ratio as at Oct 2026
NYSE:RGA P/E Ratio as at Oct 2026

Next Steps

Mixed signals in the Reinsurance Group of America story so far. Move quickly, review the full picture, and weigh both the upside and the concerns in 4 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Reinsurance Group of America?

If you stop with Reinsurance Group of America, you miss a wider field of opportunities that could suit your goals, risk comfort and income needs.

  • Target value-focused opportunities and compare Reinsurance Group of America with a broader pool of potentially mispriced businesses using 33 high quality undervalued stocks.
  • Build a steadier income stream and line up alternatives to Reinsurance Group of America by reviewing a curated set of high-yield payers through 8 dividend fortresses.
  • Reduce portfolio stress and balance out your exposure around Reinsurance Group of America by scanning 32 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.